Combination of gemcitabine and cisplatin for biliary tract cancer: A platform to build on
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference7 articles.
1. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas;Everhart;Gastroenterology,2009
2. Systemic therapy for biliary tract cancers;Hezel;Oncologist,2008
3. Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer;Meyerhardt;Dig Dis Sci,2008
4. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010
5. Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study;Valle;Br J Cancer,2009
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma;Frontiers in Bioscience-Landmark;2023-04-19
2. The epidemiological trends of biliary tract cancers in the United States of America;BMC Gastroenterology;2022-12-29
3. FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?;Cells;2022-12-05
4. Survival and Causes of Death among Patients with Intrahepatic Cholangiocarcinoma in the United States from 2000 to 2018;Cancer Epidemiology, Biomarkers & Prevention;2022-09-13
5. The epidemiological trends of Biliary tract cancers in United States;2022-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3